Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

1998-01-08

Original market date: See footnote 1

1998-01-08

Product name:

ISOVUE 370 INJECTION

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02229048

Product Monograph/Veterinary Labelling:

Date: 2017-11-17 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

BRACCO IMAGING CANADA
11065 Boul. L-H Lafontaine
Ville D'Anjou
Quebec
Canada  H1J 2Z4

Class: 

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravascular

Number of active ingredient(s):

1

Schedule(s):

Ethical  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

36:68.00   ROENTGENOGRAPHY

Anatomical Therapeutic Chemical (ATC): See footnote 4

V08AB04  IOPAMIDOL

Active ingredient group (AIG) number:See footnote 5

0116899001

List of active ingredient(s)
Active ingredient(s) Strength
IOPAMIDOL 76 %

Application information

Related information

Contact us

Version 3.8.0
Date modified: